British Journal of Cancer · 2009 · 74 citations · 15 references
PharmacyOncologyPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisOutcomes ResearchHealth State UtilitiesHealth State ValuationHealth-state Utility MeasurementOutcome ValuationPatient PreferencesUtility Elicitation MethodsClinical Utility AnalysisCost-effectivenessPreference-based Health State ValuationPreference-based MeasurementPreference-based Utility MeasurementTreatment ResponsivenessUtilities MeasurementUtility Measurement In Oncology
BACKGROUND: No studies measure preference-based utilities in advanced melanoma that capture both intended clinical response and unintended toxicities associated with treatment. METHODS: Using standard gamble, utilities were elicited from 140 respondents in the United Kingdom and Australia for 13 health states. RESULTS: Preferences decreased with reduced treatment responsiveness and with increasing toxicity. CONCLUSIONS: These general population utilities can be incorporated into treatment-specific cost-effectiveness evaluations.
15
WHO Handbook for Reporting Results of Cancer Treatment
M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text
Medicine, Oncology, Cancer Control +11
Edward L. Korn, Ping-Yu Liu, Sandra J. Lee et al. · Journal of Clinical Oncology · 2008 · 700 citations · Full text
Medicine, Biostatistics, Oncology +16